Deupirfenidone (LYT-100) in post-acute sequelae of SARS-CoV-2 with respiratory complications.

deupirfenidone (LYT-100) - PureTech

http://www.ncbi.nlm.nih.gov/pubmed/40692836

Camilla S Graham; Joel Santiaguel; Julie Krop; Mark Harnett; Michael C Chen; Raminder Aul; Tejaswini Kulkarni; Toby M Maher

Jul 22, 2025